• Advertise
  • Contact Us
  • Write For Us
  • Our Team
Extraction Magazine
No Result
View All Result
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
No Result
View All Result
Extraction Magazine
No Result
View All Result
Home Industry News

CONGRESSIONAL COMMITTEE DEBATES CANNABIS POLICY

Shared Content by Shared Content
February 3, 2020
in Industry News
CONGRESSIONAL COMMITTEE DEBATES CANNABIS POLICY

House Energy and Commerce Subcommittee on Health Considering “Cannabis Policies for the New Decade”

READ ALSO

FECO vs RSO: What Extraction Operators Can Learn From Food and Supplement Manufacturing

Solventless Extraction Methods Explained: What Food and Supplement Manufacturing Can Teach Operators

Washington, DC: Members of the House Energy and Commerce Subcommittee on Health held a legislative hearing, “Cannabis Policies for the New Decade,” during which they considered multiple legislative bills aimed at amending federal cannabis laws. This marks the first time that members of the Energy and Commerce Committee have debated issues specific to cannabis policy reform.

“At a time when nearly 70 percent of all Americans want to end our failed federal policy of blanket cannabis criminalization, it is unfortunate to see so many participants at this hearing advocating largely for business as usual,” said NORML Executive Director Erik Altieri. He continued: “The fact of the matter is that legalization and regulation work. Eleven states regulate the adult use of [cannabis] and 33 states provide for medical cannabis access. The time for federal policy to reflect this political and cultural reality is now, Congress should promptly approve the MORE Act and put the failed legacy of [cannabis] criminalization behind us.”

NORML Deputy Director Paul Armentano expressed disappointment that Committee members failed to advance any of the bills before it but was not surprised. “Many of these proposals, like The MORE Act, seek to fundamentally change federal [cannabis] policies,” he said. “However, the witnesses before the committee are proponents and purveyors of the status quo.”

He added that a key-word search on PubMed, the repository for peer-reviewed research, identifies some 32,000 studies specific to cannabis and its constituents. “While additional research is always welcome, it is not accurate to claim that we do not already have ample data to make evidence-based decisions with regard to [cannabis] policy,” he said.

Cannabis Caucus Co-Chair Representative Earl Blumenauer (D-OR) stated, “I’m pleased Chairman Pallone and Health Subcommittee Chair Eshoo made this hearing a priority. It was important to hear a number of senior members of Congress affirming the change that is taking place at the state level and affirming the contradictions that are created by the federal government being out of step and out of touch. It’s past time for Congress to catch up with the American people.”

The legislative hearing covered six cannabis-related bills, including HR 3884, the MORE Act, which recently was approved in the House Judiciary Committee by a bipartisan vote of 24-10 and waived by the House Small Business Committee.

Committee members announced their intent to hold a follow up hearing in the near future.

Witnesses at the hearing were:

Matthew J. Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration (DEA)

Douglas Throckmorton, M.D., Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research, Food and Drug Administration (FDA)

Nora D. Volkow, M.D., Director, National Institute on Drug Abuse National Institutes of Health (NIDA)

###

NORML’s mission is to move public opinion sufficiently to legalize the responsible use of marijuana by adults, and to serve as an advocate for consumers to assure they have access to high-quality marijuana that is safe, convenient, and affordable.

Find out more at www.norml.org and read our factsheets on the most common misconceptions and myths regarding reform efforts around the country at www.norml.org/marijuana/fact-sheets

Contact:
NORML
(202) 483-5500
media@norml.org

Related Posts

Botanical Extraction

FECO vs RSO: What Extraction Operators Can Learn From Food and Supplement Manufacturing

November 19, 2026
Botanical Extraction

Solventless Extraction Methods Explained: What Food and Supplement Manufacturing Can Teach Operators

November 18, 2026
Botanical Extraction

What Is Full Spectrum Extract? Lessons From Food, Pharma and Supplements for Extraction Operators

November 18, 2026
Botanical Extraction

Live Resin vs Live Sugar vs Live Rosin: What Food and Pharma Quality Systems Teach Extractors

November 16, 2026
Botanical Extraction

Top 10 Plants Used for Hydrosol Production, and the Quality Lessons Each One Teaches

November 15, 2026
Botanical Extraction

What Is Steam Distillation? Lessons From Food, Pharma and Supplements for Extraction Operators

November 15, 2026
Next Post
CONGRESS SHOULD MAKE CANNABIS RESEARCH LESS CUMBERSOME, APA TESTIFIES

CONGRESS SHOULD MAKE CANNABIS RESEARCH LESS CUMBERSOME, APA TESTIFIES

Sitemap

© 2026 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.

No Result
View All Result
  • Industry News
  • Botanical Extraction
  • Medical Research
  • Medical Research
  • Glossary
  • Our Team
  • Write For Us

© 2026 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.